Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...

The FDA has approved a new pneumococcal vaccine from Merck & Co, just over a month after Pfizer got a green light for a new version of its market leading Prevnar shot. Merck's Vaxneuvance ...

Pfizer’s pneumococcal shots, Prevnar 20 and Prevnar 13 ... Merck had hoped its new pneumococcal vaccine Capvaxive would give ...

Pfizer has been the undisputed leader in the pneumococcal vaccine market for years, gradually adding new versions of Prevnar that expand the number of serotypes covered, but analysts think that ...

AV0328, one of Alopexx’s lead candidates, is a synthetic PNAG vaccine that has completed a phase 1 trial. The biotech is ...

Pneumococcal 20-valent conjugate vaccine (diphtheria CRM197 protein); contains a total of 46.2mcg saccharides per 0.5mL; susp for IM inj; contains aluminum. After shipping, Prevnar 20 may arrive ...

This vaccine protects against pneumococcal infections ... Helps protect against 15 types of pneumococcal bacteria. PCV20 (Prevnar 20): For adults. Helps protect against 20 types of pneumococcal ...

Sales of Prevnar family of vaccines declined in the last two quarters due to fewer adult vaccinations in the United States and lower pediatric indication sales in certain emerging markets and ...

pneumococcal vaccine Prevnar 20 and respiratory syncytial virus (RSV) vaccine Abrysvo. Pfizer's pipeline features several other vaccines that are in development. They include C. Difficile vaccine ...

Among Pfizer’s biggest drugs, its blockbuster pneumonia vaccine franchise Prevnar and top-selling cancer drug Ibrance met sales expectations in the quarter. The blood-thinner Eliquis and rare ...

On the flip side, vaccines Prevnar and Abrysvo underperformed expectations. RSV vaccine Abrysvo specifically floundered in the fourth quarter. The product's sales fell 62% year over year to $198 ...